# A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

Source: https://onco.cc/trials/nct06563479/  
OnCo record `nct06563479` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of F-MISO (JBS-003) run by Memorial Sloan Kettering Cancer Center, now recruiting.

## Summary

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer is a phase 3 interventional study registered as NCT06563479 by Memorial Sloan Kettering Cancer Center, with 291 participants planned, started 2024-08-19. Conditions recorded: HPV-Related Squamous Cell Carcinoma. Interventions recorded: FMISO-PET Scan, Chemoradiation, Chemoradiation and Assessments.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06563479
- Phase: 3
- Setting: Phase III Randomized and Double-blinded Trial of De-escalated Radiation in FMISO PET-selected Good Risk Versus Standard of Care Radiation in Unselected HPV Positive Oropharyngeal Cancer
- Sponsor: Memorial Sloan Kettering Cancer Center
- Enrolled: 291

## Sources

- ClinicalTrials.gov NCT06563479: https://clinicaltrials.gov/study/NCT06563479

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/)
- drugs: [F-MISO (JBS-003)](https://onco.cc/drugs/jbs-003/)
- companies: [Juniper Biosciences](https://onco.cc/companies/juniper-biosciences/)

---
JSON: https://onco.cc/api/v1/entities/nct06563479.json